Mark Weeks

    • Auxogyn and Fertility Authority Announce Merger 

    • Guardant Health Series D Financing 

    • Iconic Therapeutics Series C Financing 

    • Nexvet Biopharma Closes Initial Public Offering 

    • CardioKinetix Completes $50 Million Financing 

    • ProteinSimple $300 Million Sale to Techne Corporation 

    • Revance $110 Million Initial Public Offering 

    • Apollo Endosurgery Agreement Acquire Obesity Intervention Division of Allergan 

    • Depomed $240 Million Diabetes Drug Sale to PDL BioPharma 

    • AcelRx Pharmaceuticals in Public Offering 

    • IDEV Technologies $310 Million Acquisition by Abbott Labs